{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:12:25Z","timestamp":1791202345215,"version":"4.2.0"},"reference-count":42,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"accepted":{"date-parts":[[2000,6,22]]},"published-print":{"date-parts":[[2000,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>AIM<\/jats:title>\n                    <jats:p>This study describes the long term follow up of haemophilic patients infected with hepatitis C virus (HCV) between 1961 and 1985.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Clinical and treatment records from 310 patients with inherited coagulation disorders treated with blood product before 1985 were reviewed. Standard survival analysis methods were used to model progression to liver failure and death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 298\/305 (98%) patients tested were anti-HCV positive. Twenty seven (9%) individuals consistently HCV polymerise chain reaction negative were considered to have cleared the virus. By 1 September 1999, 223\/310 (72%) were alive, 26 (8%) had died a liver related death, and 61 (20%) had died from other, predominantly human immunodeficiency virus (HIV) related, causes. Kaplan-Meier progression rates to death from any cause and liver related deaths 25 years after exposure to HCV were 47% (95% confidence intervals (CI) 34\u201360) and 19% (95% CI 10\u201327), respectively. After 13.3 years from 1985, by which time all patients had seroconverted to HIV, progression rates to death from any cause and liver related deaths were, respectively, 8% (95% CI 4\u201313) and 3% (95% CI 0.4\u20136) for those HIV negative, and 57% (95% CI 48\u201366) and 21% (95% CI 13\u201331) for those HIV positive (p=0.0001). Using Cox proportional hazard models, the adjusted relative hazard of death for individuals coinfected with HIV compared with those infected with HCV alone was 19.47 (95% CI 9.22\u201341.10), 0.99 (95% CI 0.39\u20132.53), 3.47 (95% CI 1.40\u20138.63), and 9.74 (95% CI 3.91\u201324.26) for the age groups at infection 10\u201319 years, 20\u201329 years, and &gt;30 years, respectively, compared with the age group &lt;10 years. The adjusted relative hazard for genotype 1 compared with other genotypes was 2.7 (95% CI 1.36\u20135.15) .<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>While 25 year follow up of 310 haemophilic patients has shown the potentially lethal combination of HIV and HCV coinfection, HCV singly infected individuals show slow progression of liver disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gut.47.6.845","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:32:32Z","timestamp":1027751552000},"page":"845-851","source":"Crossref","is-referenced-by-count":139,"title":["The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985"],"prefix":"10.1136","volume":"47","author":[{"given":"T T","family":"Yee","sequence":"first","affiliation":[{"name":"aHaemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, UK, \n\nbDepartment of Population Sciences and Primary Care, Royal Free and University College Medical School, University College, London, UK, \n\ncDepartment of Medicine, Royal Free and University College Medical School, University College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Griffioen","sequence":"additional","affiliation":[{"name":"aHaemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, UK, \n\nbDepartment of Population Sciences and Primary Care, Royal Free and University College Medical School, University College, London, UK, \n\ncDepartment of Medicine, Royal Free and University College Medical School, University College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Sabin","sequence":"additional","affiliation":[{"name":"aHaemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, UK, \n\nbDepartment of Population Sciences and Primary Care, Royal Free and University College Medical School, University College, London, UK, \n\ncDepartment of Medicine, Royal Free and University College Medical School, University College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Dusheiko","sequence":"additional","affiliation":[{"name":"aHaemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, UK, \n\nbDepartment of Population Sciences and Primary Care, Royal Free and University College Medical School, University College, London, UK, \n\ncDepartment of Medicine, Royal Free and University College Medical School, University College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Lee","sequence":"additional","affiliation":[{"name":"aHaemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, UK, \n\nbDepartment of Population Sciences and Primary Care, Royal Free and University College Medical School, University College, London, UK, \n\ncDepartment of Medicine, Royal Free and University College Medical School, University College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2000,12,1]]},"reference":[{"key":"2025120520325077000_47.6.845.1","first-page":"341","article-title":"Hepatitis C: global prevalence.","volume":"72","year":"1997","journal-title":"Wkly Epidemiol Rec"},{"key":"2025120520325077000_47.6.845.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05413-5"},{"key":"2025120520325077000_47.6.845.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07444.x"},{"key":"2025120520325077000_47.6.845.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08312.x"},{"key":"2025120520325077000_47.6.845.5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.2.5544.88","article-title":"Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia.","volume":"2","author":"Bennett","year":"1967","journal-title":"BMJ"},{"key":"2025120520325077000_47.6.845.6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0038-1648439","article-title":"Production and therapeutic use of a factor XI concentrate from plasma.","volume":"67","author":"Bolton-Maggs","year":"1992","journal-title":"Thromb Haemost"},{"key":"2025120520325077000_47.6.845.7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.1989.tb07688.x","article-title":"Interferon therapy for chronic non-A, non-B and chronic delta liver disease in haemophilia.","volume":"72","author":"Lee","year":"1989","journal-title":"Br J Haematol"},{"key":"2025120520325077000_47.6.845.8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2516.1995.tb00040.x","article-title":"Alpha interferon for hepatitis C virus infection in haemophiliac patients.","volume":"1","author":"Telfer","year":"1995","journal-title":"Haemophilia"},{"key":"2025120520325077000_47.6.845.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80225-X"},{"key":"2025120520325077000_47.6.845.10","first-page":"262","article-title":"Interferon-alpha-2B\/ribavirin combination therapy for chronic genotype 1 HCV in haemophilic patients\u2014early results.","volume":"4","author":"Bhagani","year":"1998","journal-title":"Haemophilia"},{"key":"2025120520325077000_47.6.845.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb00257.x"},{"key":"2025120520325077000_47.6.845.12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.6.639"},{"key":"2025120520325077000_47.6.845.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2007.x"},{"key":"2025120520325077000_47.6.845.14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2257.1999.00198.x","article-title":"Management of liver failure in a haemophilic patient co-infected with HIV and HCV.","volume":"21","author":"Nitu","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"2025120520325077000_47.6.845.15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1445-5994.1990.tb00372.x","article-title":"Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity and effects of immunosuppressive therapy on disease progression.","volume":"20","author":"Schoeman","year":"1990","journal-title":"Aust N Z J Med"},{"key":"2025120520325077000_47.6.845.16","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90405-8"},{"key":"2025120520325077000_47.6.845.17","first-page":"602","article-title":"Natural history of hepatitis C virus infection in multitransfused haemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Haemophilia Cohort Study.","volume":"6","author":"Eyster","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025120520325077000_47.6.845.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","article-title":"Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis.","volume":"26","author":"Soto","year":"1997","journal-title":"J Hepatol"},{"key":"2025120520325077000_47.6.845.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05038.x"},{"key":"2025120520325077000_47.6.845.20","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V84.4.1020.1020","article-title":"Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease.","volume":"84","author":"Eyster","year":"1994","journal-title":"Blood"},{"key":"2025120520325077000_47.6.845.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80496-5"},{"key":"2025120520325077000_47.6.845.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.1996.tb00084.x"},{"key":"2025120520325077000_47.6.845.23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260704"},{"key":"2025120520325077000_47.6.845.24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1440-1746.1995.tb01344.x","article-title":"Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: a multi-institution analysis.","volume":"10","author":"Yamada","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"2025120520325077000_47.6.845.25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230406"},{"key":"2025120520325077000_47.6.845.26","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(94)90046-9"},{"issue":"4 suppl","key":"2025120520325077000_47.6.845.27","first-page":"153A","article-title":"Genotypes in the progression of hepatitis C related cirrhosis and development of hepatocellular carcinoma.","volume":"24","author":"Romeo","year":"1996","journal-title":"Hepatology"},{"key":"2025120520325077000_47.6.845.28","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.1.164"},{"key":"2025120520325077000_47.6.845.29","unstructured":"Hatzakis A Touloumi G Karafoulidou A (1998) Hepatitis C virus (HCV) genotypes and progression of HIV infection in hemophiliacs. 12th World AIDS Conference, Geneva; June 28\u2013July 3, p 147."},{"key":"2025120520325077000_47.6.845.30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.1995.tb00123.x","article-title":"Hepatitis C virus genotypes in multi-transfused individuals.","volume":"1 (suppl 4)","author":"Jarvis","year":"1995","journal-title":"Haemophilia"},{"key":"2025120520325077000_47.6.845.31","doi-asserted-by":"publisher","DOI":"10.1086\/314708"},{"key":"2025120520325077000_47.6.845.32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jmv.1890450302","article-title":"Hepatitis C infection and viremia in Dutch hemophilia patients.","volume":"45","author":"Mauser-Bunschoten","year":"1995","journal-title":"J Med Virol"},{"key":"2025120520325077000_47.6.845.33","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90076-N"},{"key":"2025120520325077000_47.6.845.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904223401602"},{"key":"2025120520325077000_47.6.845.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909163411202"},{"key":"2025120520325077000_47.6.845.36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260707"},{"key":"2025120520325077000_47.6.845.37","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(91)90042-T"},{"key":"2025120520325077000_47.6.845.38","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(91)90116-D"},{"key":"2025120520325077000_47.6.845.39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/hep.510260706","article-title":"Hepatitis C and hepatocellular carcinoma.","volume":"26 (suppl 1)","author":"Di Bisceglie","year":"1997","journal-title":"Hepatology"},{"key":"2025120520325077000_47.6.845.40","doi-asserted-by":"publisher","DOI":"10.1136\/gut.22.10.854"},{"key":"2025120520325077000_47.6.845.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07124-4"},{"key":"2025120520325077000_47.6.845.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392101"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.47.6.845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:33:04Z","timestamp":1764995584000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.47.6.845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12,1]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2000,12,1]]},"published-print":{"date-parts":[[2000,12,1]]}},"alternative-id":["10.1136\/gut.47.6.845"],"URL":"https:\/\/doi.org\/10.1136\/gut.47.6.845","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12,1]]}}}